Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Japan Looking To Western Countries For Generic Drug Utilization Tips

This article was originally published in PharmAsia News

Executive Summary

Japan's Ministry of Health, Labor and Welfare will send a research group to the U.S., U.K. and France in February, to study price setting and logistical systems being used in the pharmaceutical industries there, the MHLW announced Jan. 29.The research will focus on how to promote generic drugs in Japan to bring new ideas to the drug re-pricing discussions in April, said the MHLW

Table

View full table

Tags:
Latest Headlines

Pipeline Watch: Eighteen Approvals And Six Phase III Trial Updates

Bolar Exemption India Files: Roche Blocks Alleged Infringer Of Evrysdi Patent

Finance Watch: Investors Support Strategic Shifts At Cullinan, Cidara

Humira Market Erosion Is Continuing As Expected, AbbVie Says

See All
UsernamePublicRestriction

Register

SC067652

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By